Can the standard treatment of acute spinal cord injury be improved? Perhaps the time has come

Neurological Research

Volumn 29, Issue 1, 2007, Pages 16-20

  Goldsmith, Harry S ^a  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

Dimethyl sulfoxide (DMSO); Methylprednisolone; Omentum; Omentum stem cells; Omentum transposition

Indexed keywords

DEXAMETHASONE; DIMETHYL SULFOXIDE; FIBRIN; FIBRINOGEN; FLUNIXIN MEGLUMINE; MANNITOL; METHYLPREDNISOLONE; NEUROPROTECTIVE AGENT; OXYGEN; STEROID; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DURA MATER; EDEMA; HYPERBARIC OXYGEN; LAMINECTOMY; NEUROPROTECTION; NONHUMAN; OMENTAL PEDICLE; OMENTUM; OMENTUM TRANSPLANTATION; SCAR; SPINAL CORD; SPINAL CORD INJURY; SPINAL CORD SURGERY; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

ACUTE DISEASE; ANIMALS; CATS; CICATRIX; DIMETHYL SULFOXIDE; DURA MATER; EDEMA; HUMANS; NEUROPROTECTIVE AGENTS; NEUROSURGICAL PROCEDURES; OMENTUM; QUALITY ASSURANCE, HEALTH CARE; SPINAL CORD INJURIES; TISSUE TRANSPLANTATION; TREATMENT OUTCOME;

EID: 33846571386     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164106X130434     Document Type: Article

References (41)

1. Hulbert RJ. Methylprednisolone for acute spinal cord injury: An inappropriate standard of care. J Neurosurg 2000; 93: 1-7
2. Qian T, Guo X, Levi AD, et al. High-dose methylprednisolone may cause myopathy in acute spinal cord injury patients. Spinal Cord 2005; 43: 199-203
3. Bracken MB, Shepard MJ, Holford TR, et al. Administration of methylprednisolone for 24 or 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA 1997; 277: 1597-1604
4. Hanson P, Dive A, Brucher JM, et al. Acute corticosteroid myopathy in intensive care patients. Muscle Nerve 1997; 20: 1371-1380
5. Kajihara K, Kawanaga H, de la Torre JC, et al. Dimethyl sulfoxide in the treatment of experimental acute spinal cord injury. Surg Neurol 1973; 1: 16-22
6. de la Torre JC, Johnson CM, Goode DJ, et al. Pharmacologic treatment and evaluation of permanent experimental spinal cord trauma. Neurology 1975; 25: 508-514
7. Goodnough, J, Allen N, Nesham ME, et al. The effect of dimethyl sulfoxide on gray matter injury in experimental spinal cord trauma. Surg Neurol 1980; 13: 273-276
8. Goldsmith HS, Steward E, Duckett S. Early application of pedicled omentum to the acutely traumatized spinal cord. Paraplegia 1985; 23: 100-112
9. Goldsmith HS. Application of the omentum to the brain and spinal cord. In: Goldsmith HS, ed. The Omentum: Application to Brain and Spinal Cord, Wilton, CT: Forefront Publishing, 2000: pp. 25-43
10. Matsumoto T, Tamaki T, Kawakami M, et al. Early complications of high-dose methylprednisolone sodium succinate treatment in the follow-up of acute cervical spinal cord injury. Spine 2001; 26: 426-430
11. Vaccaro AR, Daughterly RJ, Sheehan TP, et al. Neurologic outcome of early versus late surgery for cervical spinal cord injury. Spine 1997; 22: 2609-2613
12. McKinley W, Meade MA, Kirshblum S, et al. Outcomes of early surgical management versus late or no surgical intervention after acute spinal cord injury. Arch Phys Med Rehabil 2004; 85: 1818-1825
13. Goldsmith HS. Omental transposition to the spinal cord. In: Ostrander LE, Lee BY, eds. The Spinal Cord Injured Patient; New York, NY: Demos Publishers, 2002: pp. 381-394
14. Mascalchi M, Dal Pozzo G, Dini C, et al. Acute spinal cord trauma: Prognostic value of MRI appearance at 0.5 T. Clin Radiol 1993; 48: 100-108
15. Silberstein M, Tress BM, Hennessy O. Prediction of neurologic outcome in acute spinal cord injury: The role of CT and MR. AJNR Am J Neuroradiol 1992; 13: 1597-1608
16. Elrai S, Souei M, Arifa N, et al. [MR imaging in spinal cord injury]. J Radiol 2006; 87: 121-126
17. Andreoli C, Colaiacomo MC, Rojas Beccaglia M, et al. MRI in the acute phase of spinal cord traumatic lesions: Relationship between MRI findings and neurological outcome. Radiol Med (Torino) 2005; 110: 636-645
18. Boldin C, Raith J, Fankhauser F, et al. Predicting neurologic recovery in cervical spinal cord injury with postoperative MR imaging. Spine 2006; 31: 554-559
19. Shepard MJ, Bracken MB. Magnetic resonance imaging and neurological recovery in acute spinal cord injury: Observation from the National Acute Spinal Cord Injury Study 3. Spinal Cord 1999; 37: 833-837
20. Levander B, Zwetnow NN. Bulk flow of cerebrospinal fluid through a lumbo-omental pedicle graft in the dog. Acta Neurochir 1978; 41: 147-155
21. Goldsmith HS. Revascularization and edema absorption of the brain and spinal cord. In: Liebermann-Meffert D, White H, eds. The Greater Omentum, New York, NY: Springer-Verlag, 1990: pp. 189-197
22. Goldsmith HS, de los Santos R, Beattie EJ, Jr. Relief of chronic lymphedema by omental transposition. Ann Surg 1967; 166: 572-585
23. Shimada Y. Experimental study on effect of omental transposition in cats with spinal cord injury. No To Shinkei 1995; 47: 863-873
24. Abraham J, Paterson A, Bothra M, et al. Omental-myelosynangiosis in the management of chronic traumatic paraplegia: Case report. Paraplegia 1987; 25: 44-49
25. Nagashima C, Masumori Y, Hod E, et al. Omental transposition to the cervical cord with macroangio anastomosis. No Shinkei Geka 1991; 19: 309-318
26. Rafael H, Malpica A, Espinoza M, et al. Omental transplantation in the management of chronic traumatic paraplegia. Case report. Acta Neurochir (Wien) 1992; 114: 145-146
27. Goldsmith HS. First International Congress of Omentum to the CNS. Surg Neurol 1996; 45: 87-90
28. Goldsmith HS, Griffith AL, Kupferman A, et al. Lipid angiogenic factor from omentum. JAMA 1984; 252: 2034-2036
29. Zhang QX, Magovern CJ, Mack CA, et al. Vascular endothelial growth factor is the major angiogenic factor in omentum: Mechanism of the omentum-mediated angiogenesis. J Surg Res 1997; 67: 147-154
30. Cartier R, Brunette I, Hashimoto K, et al. Angiogenic factor: A possible mechanism for neovascularization produced by omental pedicles. J Thorac Cardiovasc Surg 1990; 99: 264-268
31. Goldsmith HS, Griffith AL, Catsimpoolas N, et al. Increased vascular perfusion after administration of an omental lipid fraction. Surg Gynecol Obstet 1986; 162: 579-583
32. Dujovny M, Ding YH, Ding Y, et al. Current concepts on the expression of neurotrophins in the greater omentum. Neurol Res 2004; 26: 226-229
33. Siek GC, Marquis JK, Goldsmith HS. Experimental studies of omentum derived neurotrophic factors. In: Goldsmith HS, ed. The Omentum: Research and Clinical Applications, New York/Berlin: Springer-Verlag, 1990: pp. 83-95
34. Goldsmith HS, McIntosh T, Vezena RM, et al. Vasoactive neurochemicals identified in omentum: A preliminary report. Br J Neurosurg 1987; 1: 359-364
35. Goldsmith HS, Marquis JK, Siek G. Choline acetyltransferase activity in omental tissue. Br J Neurosurg 1987; 1: 463-166
36. Lu D, Li Y, Wang L, et al. Intraarterial administration of marrow stromal cells in a rat model of traumatic brain injury. J Neurotrauma 2001; 18: 813-819
37. Pluchino S, Quattrini A, Brambilla E, et al. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 2000; 422: 688-694
38. Yandava BD, Billinghurst LL, Snyder EY. "Global" cell replacement is feasible via neural stem cell transplantation: Evidence from the dysmyelinated shiverer mouse brain. Proc Natl Acad Sci USA 1999; 96: 7029-7034
39. Bakshi A, Hunter C, Swanger S, et al. Minimally invasive delivery of stem cells for spinal cord injury: Advantages of the lumbar puncture technique. J Neurosurg Spine 2004; 1: 330-337
40. Garcia-Gomez I, Goldsmith HS, Angulo J, et al. Angiogenic capacity of human omental stem cells. Neurol Res 2005; 27: 807-811
41. Thorn SR, Bhopale VM, Velasquez DC, et al. Stem cell mobilization by hyperbaric oxygen. Am J Physiol Heart Circ 2006; 290: H1378-H1386